2018-2023 UK Cancer Treatment Drugs Market Report (Status and Outlook)

October 2018 | 88 pages | ID: 2F153FE54F8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In 2017, the Cancer Treatment Drugs market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In UK market, the top players include

• Roche
• Novartis
• Celgene
• Bristol-Myers Squibb
• Amgen
• Johnson & Johnson
• Pfizer
• Takeda
• Eli Lilly
• AstraZeneca
• Astellas
• Merck & Co.
• Sanofi
• Bayer
• Biogen Idec
• Eisai
• Teva
• Otsuka
• Merck KGaA
• Ipsen
• AbbVie
• Gilead Sciences

Split by product types/category, covering

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy (Biologic Therapy)
• Others

Split by applications/end use industries, covers

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Other Cancers

Contents

2018-2023 UK CANCER TREATMENT DRUGS MARKET REPORT (STATUS AND OUTLOOK)

1 CANCER TREATMENT DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Market Segment by Types
  1.2.1 UK Cancer Treatment Drugs Sales Present Situation and Outlook by Types (2013-2023)
  1.2.2 UK Cancer Treatment Drugs Sales Market Share by Types in 2017
  1.2.3 Chemotherapy
    1.2.3.1 Major Players of Chemotherapy
  1.2.4 Targeted Therapy
    1.2.4.1 Major Players of Targeted Therapy
  1.2.5 Immunotherapy
    1.2.5.1 Major Players of Immunotherapy
  1.2.6 Hormonal Therapy (Biologic Therapy)
    1.2.6.1 Major Players of Hormonal Therapy (Biologic Therapy)
  1.2.7 Others
    1.2.7.1 Major Players of Others
1.3 UK Cancer Treatment Drugs Market Segment by Applications/End Use Industries
  1.3.1 UK Cancer Treatment Drugs Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
  1.3.2 UK Cancer Treatment Drugs Sales Market Share by Applications in 2017
  1.3.2 Blood Cancer
  1.3.3 Breast Cancer
  1.3.4 Gastrointestinal Cancer
  1.3.5 Prostate Cancer
  1.3.6 Respiratory/Lung Cancer
  1.3.7 Other Cancers
1.4 UK Cancer Treatment Drugs Overview and Market Size (Value) (2013-2023)
  1.4.1 UK Market Cancer Treatment Drugs Overview
  1.4.2 UK Cancer Treatment Drugs Market Size (Value and Volume) Status and Forecast (2013-2023)

2 UK CANCER TREATMENT DRUGS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 UK Cancer Treatment Drugs Sales and Market Share by Players (2013-2018)
2.2 UK Cancer Treatment Drugs Revenue and Market Share by Players (2013-2018)
2.3 UK Cancer Treatment Drugs Average Price by Players in 2017
2.4 UK Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Cancer Treatment Drugs Market Competitive Situation and Trends
  2.5.1 Cancer Treatment Drugs Market Concentration Rate
  2.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Players in 2017
  2.5.3 Mergers & Acquisitions, Expansion

3 UK CANCER TREATMENT DRUGS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2013-2018)

3.1 UK Cancer Treatment Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
  3.1.1 UK Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
  3.1.2 UK Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
  3.1.3 UK Cancer Treatment Drugs Price by Type (2013-2018)
3.2 UK Cancer Treatment Drugs Sales and Market Share by Application (2013-2018)
3.3 UK Market Cancer Treatment Drugs Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)

4 UK CANCER TREATMENT DRUGS PLAYERS PROFILES AND SALES DATA

4.1 Roche
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Roche News
4.2 Novartis
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Novartis News
4.3 Celgene
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Celgene News
4.4 Bristol-Myers Squibb
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Bristol-Myers Squibb News
4.5 Amgen
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Amgen News
4.6 Johnson & Johnson
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Johnson & Johnson News
4.7 Pfizer
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Pfizer News
4.8 Takeda
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Takeda News
4.9 Eli Lilly
  4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.9.2 Cancer Treatment Drugs Product Types, Application and Specification
    9.9.2.1 Type
    9.9.2.2 Type
  4.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.9.4 Main Business/Business Overview
  4.9.5 Eli Lilly News
4.10 AstraZeneca
  4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.10.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.10.2.1 Type
    4.10.2.2 Type
  4.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.10.4 Main Business/Business Overview
  4.10.5 AstraZeneca News
4.11 Astellas
  4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.11.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.11.2.1 Type
    4.11.2.2 Type
  4.11.3 Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.11.4 Main Business/Business Overview
  4.11.5 Astellas News
4.12 Merck & Co.
  4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.12.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.12.2.1 Type
    4.12.2.2 Type
  4.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.12.4 Main Business/Business Overview
  4.12.5 Merck & Co. News
4.13 Sanofi
  4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.13.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.13.2.1 Type
    4.13.2.2 Type
  4.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.13.4 Main Business/Business Overview
  4.13.5 Sanofi News
4.14 Bayer
  4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.14.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.14.2.1 Type
    4.14.2.2 Type
  4.14.3 Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.14.4 Main Business/Business Overview
  4.14.5 Bayer News
4.15 Biogen Idec
  4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.15.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.15.2.1 Type
    4.15.2.2 Type
  4.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.15.4 Main Business/Business Overview
  4.15.5 Biogen Idec News
4.16 Eisai
  4.16.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.16.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.16.2.1 Type
    4.16.2.2 Type
  4.16.3 Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.16.4 Main Business/Business Overview
  4.16.5 Eisai News
4.17 Teva
  4.17.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.17.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.17.2.1 Type
    4.17.2.2 Type
  4.17.3 Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.17.4 Main Business/Business Overview
  4.17.5 Teva News
4.18 Otsuka
  4.18.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.18.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.18.2.1 Type
    4.18.2.2 Type
  4.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.18.4 Main Business/Business Overview
  4.18.5 Otsuka News
4.19 Merck KGaA
  4.19.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.19.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.19.2.1 Type
    4.19.2.2 Type
  4.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.19.4 Main Business/Business Overview
  4.19.5 Merck KGaA News
4.20 Ipsen
  4.20.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.20.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.20.2.1 Type
    4.20.2.2 Type
  4.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.20.4 Main Business/Business Overview
  4.20.5 Ipsen News
4.21 AbbVie
  4.21.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.21.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.21.2.1 Type
    4.21.2.2 Type
  4.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.21.4 Main Business/Business Overview
  4.21.5 AbbVie News
4.22 Gilead Sciences
  4.22.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.22.2 Cancer Treatment Drugs Product Types, Application and Specification
    4.22.2.1 Type
    4.22.2.2 Type
  4.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  4.22.4 Main Business/Business Overview
  4.22.5 Gilead Sciences News

5 UK CANCER TREATMENT DRUGS MARKET FORECAST (2018-2023)

5.1 UK Cancer Treatment Drugs Sales, Revenue and Price Forecast (2018-2023)
  5.1.1 UK Cancer Treatment Drugs Sales and Growth Rate Forecast (2018-2023)
  5.1.2 UK Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2023)
  5.1.3 UK Cancer Treatment Drugs Price Trend Forecast (2018-2023)
5.2 UK Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
5.3 UK Cancer Treatment Drugs Sales Forecast by Application (2018-2023)

6 PRODUCTION COST ANALYSIS OF CANCER TREATMENT DRUGS

6.1 Main Raw Materials of Cancer Treatment Drugs
  6.1.1 List of Cancer Treatment Drugs Main Raw Materials
  6.1.2 Cancer Treatment Drugs Main Raw Materials Price Analysis
  6.1.3 Cancer Treatment Drugs Raw Materials Major Suppliers
  6.1.4 Cancer Treatment Drugs Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Cancer Treatment Drugs
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Cancer Treatment Drugs Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cancer Treatment Drugs Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Cancer Treatment Drugs Major Players in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Cancer Treatment Drugs Distributors/Traders List in UK

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Treatment Drugs
Table Product Specifications of Cancer Treatment Drugs
Figure UK Cancer Treatment Drugs Sales (volume) for Each Type (2013-2023)
Figure UK Cancer Treatment Drugs Sales Market Share by Types in 2017
Table Types of Cancer Treatment Drugs
Figure Product Picture of Chemotherapy
Table Major Players of Chemotherapy
Figure Product Picture of Targeted Therapy
Table Major Players of Targeted Therapy
Figure Product Picture of Immunotherapy
Table Major Players of Immunotherapy
Figure Product Picture of Hormonal Therapy (Biologic Therapy)
Table Major Players of Hormonal Therapy (Biologic Therapy)
Figure Product Picture of Others
Table Major Players of Others
Figure UK Cancer Treatment Drugs Sales Present Situation and Outlook by Applications (2013-2023)
Figure UK Cancer Treatment Drugs Sales Market Share by Applications in 2017
Table Applications of Cancer Treatment Drugs
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure Gastrointestinal Cancer Examples
Figure Prostate Cancer Examples
Figure Respiratory/Lung Cancer Examples
Figure Other Cancers Examples
Figure UK Cancer Treatment Drugs Revenue (Million USD) Status and Forecast (2013-2023)
Figure UK Cancer Treatment Drugs Sales (Volume) Status and Forecast (2013-2023)
Table UK Cancer Treatment Drugs Sales by Players (2013-2018)
Table UK Cancer Treatment Drugs Sales Market Share (%) by Players (2013-2018)
Figure UK Cancer Treatment Drugs Sales Market Share by Players in 2016
Figure UK Cancer Treatment Drugs Sales Market Share by Players in 2017
Table UK Cancer Treatment Drugs Revenue (Million USD) by Players (2013-2018)
Table UK Cancer Treatment Drugs Revenue Market Share (%) by Players (2013-2018)
Figure UK Cancer Treatment Drugs Revenue Market Share by Players in 2016
Figure UK Cancer Treatment Drugs Revenue Market Share by Players in 2017
Figure UK Cancer Treatment Drugs Average Price by Players in 2017
Table UK Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Cancer Treatment Drugs Product Types
Figure Cancer Treatment Drugs Market Share of Top 3 Players in 2017
Figure Cancer Treatment Drugs Market Share of Top 5 Players in 2017
Table UK Cancer Treatment Drugs Sales by Type (2013-2018)
Table UK Cancer Treatment Drugs Sales Market Share by Type (2013-2018)
Figure UK Cancer Treatment Drugs Sales Market Share by Type in 2013
Figure UK Cancer Treatment Drugs Sales Market Share by Type in 2017
Table UK Cancer Treatment Drugs Revenue (Million USD) by Type (2013-2018)
Table UK Cancer Treatment Drugs Revenue Market Share by Type (2013-2018)
Figure UK Cancer Treatment Drugs Revenue Market Share by Type in 2013
Figure UK Cancer Treatment Drugs Revenue Market Share by Type in 2017
Table UK Cancer Treatment Drugs Price by Type (2013-2018)
Table UK Cancer Treatment Drugs Sales by Application (2013-2018)
Table UK Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure UK Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure UK Cancer Treatment Drugs Sales Market Share by Application in 2017
Table UK Market Cancer Treatment Drugs Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Cancer Treatment Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Treatment Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Cancer Treatment Drugs Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Treatment Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Cancer Treatment Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Cancer Treatment Drugs Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Cancer Treatment Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Treatment Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Cancer Treatment Drugs Market Share (2012-2017)
Table Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Cancer Treatment Drugs Market Share (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck & Co. Cancer Treatment Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Cancer Treatment Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Cancer Treatment Drugs Market Share (2012-2017)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Idec Cancer Treatment Drugs Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Cancer Treatment Drugs Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Cancer Treatment Drugs Market Share (2012-2017)
Table Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Cancer Treatment Drugs Market Share (2012-2017)
Table Merck KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck KGaA Cancer Treatment Drugs Market Share (2012-2017)
Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ipsen Cancer Treatment Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Cancer Treatment Drugs Market Share (2012-2017)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead Sciences Cancer Treatment Drugs Market Share (2012-2017)
Figure UK Cancer Treatment Drugs Sales and Growth Rate Forecast (2018-2023)
Figure UK Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure UK Cancer Treatment Drugs Price Trend Forecast (2018-2023)
Table UK Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Figure UK Cancer Treatment Drugs Sales Market Share Forecast by Type (2018-2023)
Figure UK Cancer Treatment Drugs Sales Market Share Forecast by Type in 2023
Table UK Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Figure UK Cancer Treatment Drugs Sales Market Share Forecast by Application (2018-2023)
Figure UK Cancer Treatment Drugs Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Cancer Treatment Drugs Main Raw Materials Price Trend
Table Cancer Treatment Drugs Raw Materials Major Suppliers List
Figure Production Cost Structure of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Manufacturing Process/Method
Figure Cancer Treatment Drugs Value Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Players in 2017
Table Major Buyers of Cancer Treatment Drugs
Table Cancer Treatment Drugs Distributors/Traders List in UK